Organic Process Research & Development
Article
Fotouhi, N.; Tilley, J.; Cohen, N.; Choudhry, S.; Cavallo, G.; Tannu, S.
A.; Ventre, J. D.; Lavelle, D.; Tare, N. S.; Oh, H.; Lamb, M.; Kurylko,
G.; Hamid, R.; Wright, M. B.; Pamidimukkala, A.; Egan, T.; Gubler,
U.; Hoffmann, A. F.; Wei, X.; Li, Y. L.; O’Neil, J.; Marcano, R.;
Pozzani, K.; Molinaro, T.; Santiago, J.; Singer, L.; Hargaden, M.;
Moore, D.; Catala, A. R.; Chao, L. C. F.; Hermann, G.; Venkat, R.;
Mancebo, H.; Renzetti, L. M. J. Med. Chem. 2010, 53, 3502.
(c) Dominique, R.; Fotouhi, N.; Gillespie, P.; Goodnow, R. A. Jr.;
Kowalczyk, A.; Qiao, Q.; Sidduri, A. PCT Int. Appl. WO/2009/
024492, February, 26, 2009; Chem. Abstr. 2009, 150, 282682.
(3) Davidson, J. P.; Sarma, K.; Fishlock, D.; Welch, M. H.;
Sukhtankar, S.; Lee, G. M.; Martin, M.; Cooper, G. F. Org. Process
Res. Dev. 2010, 14, 477.
butyric Acid Ethyl Ester (32). A mixture of 1 (1.03 kg, 3.47
mol), DMF (3.2 L) and K2CO3 (1.08 kg, 7.81 mol) was heated
to 45 °C and stirred for 20 min; then a solution of 2 (crude oil,
containing 3.57 mol of 2 in theory) in DMF (2.0 L) was added.
The mixture was stirred at 65−67 °C for 24 h and then diluted
with H2O (16 L), MTBE (24 L), and heptane (2.4 L). The
organic phase was separated and washed with aqueous K2CO3
(1.2 wt %, 2 × 8 L). Charcoal (350 g) was added, and the
resulting mixture was stirred for 20 min and then filtered
through a pad of Celite (750 g); the Celite pad was then
washed with MTBE (4.0 L). The combined filtrate and wash
were concentrated to give 322b (2.47 kg, 3.47 mol in theory) as
an oily foam which was used directly in the next step.
(4) For an example of acidic rearrangement of benzyl phenyl ethers,
see Sagrera, G.; Seoane, G. Synthesis 2009, 4190.
4-[3-[6-(3-Benzo[1,3]dioxol-5-yl-5-thiophen-3-
ylphenoxy)hexyl]-2-(2-carboxyethyl)phen-oxy]butyric
Acid (3). Two flasks were each charged with 32 (1.11 kg of oil,
containing 1.56 mol of 32 in theory), THF (4.5 L), and ethanol
(2.0 L). To each solution was added 2 M NaOH (3.25 L, 6.50
mol). The mixtures were stirred at 19−23 °C for 16 h to obtain
clear, brownish solutions. The contents of the two flasks were
combined and concentrated at 40 °C/10 mmHg to remove
THF. The residue was diluted with water (14 L) and MTBE
(18 L). The aqueous layer was separated and acidified with 4 M
HCl (3.0 L) to pH ∼1.2, while cooling with an ice−water bath.
The mixture was then diluted with EtOAc (16 L). The organic
layer was separated, washed with water (4 × 10 L), and
concentrated at 35 °C/10 mmHg. The residual oil was diluted
with CH3CN (7.5 L) and further concentrated to near dryness.
The resulting oil was diluted with CH3CN (8.5 L) and stirred
at 19−23 °C for 3 h. The precipitated solid was isolated by
filtration to give crude 3 (1.53 kg) as an off-white solid.
Crude 3 (1.53 kg) and CH3CN (4.0 L) were heated to reflux
to obtain a light-brown solution. This solution was gradually
cooled to room temperature with stirring to complete the
crystallization. The resulting solid was isolated by filtration,
washed with CH3CN (2 × 1 L), and dried to give 32b (1.26 kg,
64% yield from 31) as a white solid in 98% purity.
(5) Katritzky, A. R.; Belyakov, S. A.; Henderson, S. A.; Steel, P. J. J.
Org. Chem. 1997, 62, 8215.
(6) For examples of Claisen−Schmidt condensations, see (a) Kohler,
E. P.; Chadwell, H. M. Org. Synth. 1922, 2, 1. (b) Breslow, D. S.;
Hauser, C. R. J. Am. Chem. Soc. 1940, 62, 2385 and references cited in
ref 7.
(7) Bhagat, S.; Sharma, R.; Sawant, D. M.; Sharma, L.; Chakraborti,
A. K. J. Mol. Catal. A: Chem. 2006, 244, 20.
(8) Benzotriazole is stable at the reaction temperature. For thermal
stability of benzotriazole, see Katrizky, A. R.; Wang, Z.; Tsikolia, M.;
Hall, C. D.; Carman, M. Tetrahedron Lett. 2006, 47, 7653.
(9) Thermal hazard analysis was not conducted due to the
termination of the project.
(10) The exotherm was primarily caused by mixing KOtBu with
ethanol. When KOEt or NaOEt was used, only a mild exotherm was
observed.
(11) Eichinger, K.; Nussbaumer, P.; Balkan, S.; Schulz, G. Synthesis
1987, 1061.
(12) This approach was not further investigated due to the
termination of the project.
(13) For an example of Wittig reaction of 28, see Ohloff, G.; Vial, C.;
Naf, F.; Pawlak, M. Helv. Chim. Acta 1977, 60, 1161.
̈
(14) For an example of the decomposition of phosphonium salt, see
Grayson, M.; Keough, P. T. J. Am. Chem. Soc. 1960, 82, 3919.
(15) 1,2-Epoxybutane is highly flammable, and it could polymerize
and generate heat under certain conditions. Although it has been
widely used in Wittig reactions as acid scavenger and solvent, it is not
recommended for use at large scale.
AUTHOR INFORMATION
Corresponding Author
■
(16) Oxidation using H2O2 in flammable solvent is potentially
hazardous. It is important to maintain a constant flow of inert gas to
prevent oxygen from building up in the reaction vessel. For safe scale-
up of oxidation by H2O2 in flammable solvents, see Astbury, G. R. Org.
Process Res. Dev. 2002, 6, 893.
Notes
The authors declare no competing financial interest.
(17) The 1HNMR of 20 was in agreement with that of the structure.
(18) A complete conversion is not desired as it resulted in the
formation of a high level of a high-boiling impurity.
ACKNOWLEDGMENTS
■
We are grateful to Dr. Masami Okabe for helpful discussions.
We thank Rui Yu, Bojana Nedjic, Aaron Obdens, and Joseph
Degasperi for analytic support.
́
(19) Miesch, M.; Miesch, L.; Horvatovich, P.; Burnouf, D.; Delincee,
H.; Hartwig, A.; Raul, F.; Werner, D.; Marchioni, E. Radiat. Phys.
Chem. 2002, 65, 233.
(20) Compound 31, a mixture of E/Z (2:1) isomers, was directly
used in the next step without characterization.
REFERENCES
■
(1) For a review of the preclinical/clinical development of LTB4
receptor antagonists, see Hicks, A.; Monkarsh, S. P.; Hoffmann, A. F.;
Goodnow, R., Jr. Expert. Opin. Invest. Drugs 2007, 16, 1909.
(2) (a) Hicks, A.; Goodnow, R., Jr.; Cavallo, G.; Tannu, S. A.; Ventre,
J. D.; Lavelle, D.; Lora, J. M.; Satjawatcharaphong, J.; Brovarney, M.;
Dabbagh, K.; Tare, N. S.; Oh, H.; Lamb, M.; Sidduri, A.; Dominique,
R.; Qiao, Q.; Lou, J. P.; Gillespie, P.; Fotouhi, N.; Kowalczyk, A.;
Kurylko, G.; Hamid, R.; Wright, M. B.; Pamidimukkala, A.; Egan, T.;
Gubler, U.; Hoffmann, A. F.; Wei, X.; Li, Y. L.; O’Neil, J.; Marcano, R.;
Pozzani, K.; Molinaro, T.; Santiago, J.; Singer, L.; Hargaden, M.;
Moore, D.; Catala, A. R.; Chao, L. C. F.; Benson, J.; March, T.; Venkat,
R.; Mancebo, H.; Renzetti, L. M. Prostaglandins Other Lipid Mediators
2010, 92, 33. (b) Goodnow, R. A., Jr.; Hicks, A.; Sidduri, A.;
Kowalczyk, A.; Dominique, R.; Qiao, Q.; Lou, J. P.; Gillespie, P.;
119
dx.doi.org/10.1021/op300302s | Org. Process Res. Dev. 2013, 17, 114−119